Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,947	895.8	1,548	1,838	1,092
Short-Term Investments	-	-	-	-	2,260
Trading Asset Securities	-	-	13.4	15.36	376.28
Cash & Short-Term Investments	2,947	895.8	1,561	1,853	3,728
Cash Growth	228.98%	-42.61%	-15.76%	-50.30%	18.76%
Accounts Receivable	8,286	7,788	6,423	5,886	4,954
Other Receivables	-	193.9	172.3	96.35	135.5
Receivables	8,286	7,983	6,596	5,983	5,090
Inventory	9,750	9,932	7,443	6,288	6,083
Prepaid Expenses	-	221.2	211.3	234.32	210.48
Other Current Assets	1,023	1,348	1,656	1,561	1,372
Total Current Assets	22,006	20,380	17,467	15,919	16,484
Property, Plant & Equipment	13,038	13,100	13,172	14,026	14,823
Long-Term Investments	0.2	0.2	0.2	1.61	2.85
Goodwill	15.5	15.5	15.5	15.45	15.45
Other Intangible Assets	73.3	187	563.6	-	-
Long-Term Deferred Tax Assets	305.6	257.8	67.8	101.13	43.55
Other Long-Term Assets	1,934	1,753	1,462	1,867	1,818
Total Assets	37,374	35,694	32,750	31,930	33,188
Accounts Payable	3,566	4,026	3,513	2,907	1,832
Accrued Expenses	-	1,749	1,825	699.37	555.94
Short-Term Debt	4,297	3,403	1,553	2,081	2,157
Current Portion of Long-Term Debt	-	288.7	256.6	256.63	256.63
Current Portion of Leases	53.7	46.1	42.1	51.6	42.18
Current Income Taxes Payable	-	43.4	22.1	4.91	20.95
Current Unearned Revenue	-	9.7	76.9	245.27	269.49
Other Current Liabilities	942.8	378.1	88.3	150.56	387.32
Total Current Liabilities	8,859	9,943	7,376	6,396	5,521
Long-Term Debt	391.2	608.1	382.2	636.49	890.11
Long-Term Leases	260	251.9	241.6	114.93	145.71
Pension & Post-Retirement Benefits	-	115.1	86.2	135.07	128.81
Long-Term Deferred Tax Liabilities	398.8	-	-	-	-
Other Long-Term Liabilities	290.6	269.9	280.5	294.95	317.72
Total Liabilities	10,200	11,188	8,367	7,577	7,004
Common Stock	140.8	140.8	140.8	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3
Retained Earnings	-	24,121	23,640	23,975	25,061
Comprehensive Income & Other	27,034	230.6	588.5	223.87	969.19
Shareholders' Equity	27,174	24,506	24,383	24,353	26,184
Total Liabilities & Equity	37,374	35,694	32,750	31,930	33,188
Total Debt	5,002	4,598	2,475	3,140	3,492
Net Cash (Debt)	-2,055	-3,702	-914.3	-1,288	236.25
Net Cash Growth	-	-	-	-	-87.87%
Net Cash Per Share	-29.13	-52.42	-12.99	-18.29	3.35
Filing Date Shares Outstanding	70.39	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.39	70.41	70.41	70.41	70.41
Working Capital	13,147	10,436	10,091	9,523	10,963
Book Value Per Share	386.07	348.07	346.32	345.90	371.90
Tangible Book Value	27,086	24,303	23,804	24,338	26,169
Tangible Book Value Per Share	384.81	345.19	338.10	345.68	371.68
Land	-	37.5	37.8	37.8	37.8
Buildings	-	5,499	5,108	5,101	3,872
Machinery	-	13,362	11,908	11,587	9,123
Construction In Progress	-	306.7	1,227	1,475	4,938

Source: S&P Global Market Intelligence. Standard template. Financial Sources.